Skip to main content

Nuclear and Membrane Actions of Estrogen Receptor Alpha: Contribution to the Regulation of Energy and Glucose Homeostasis

  • Chapter
  • First Online:
Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity

Abstract

Estrogen receptor alpha (ERα) has been demonstrated to play a key role in reproduction but also to exert numerous functions in nonreproductive tissues. Accordingly, ERα is now recognized as a key regulator of energy homeostasis and glucose metabolism and mediates the protective effects of estrogens against obesity and type 2 diabetes. This chapter attempts to summarize our current understanding of the mechanisms of ERα activation and their involvement in the modulation of energy balance and glucose metabolism. We first focus on the experimental studies that constitute the basis of the understanding of ERα as a nuclear receptor and more specifically on the key roles played by its two activation functions (AFs). We depict the consequences of the selective inactivation of these AFs in mouse models, which further underline the prominent role of nuclear ERα in the prevention of obesity and diabetes, as on the reproductive tract and the vascular system. Besides these nuclear actions, a fraction of ERα is associated with the plasma membrane and activates nonnuclear signaling from this site. Such rapid effects, called membrane-initiated steroid signals (MISS), have been characterized in a variety of cell lines and in particular in endothelial cells. The development of selective pharmacological tools that specifically activate MISS as well as the generation of mice expressing an ERα protein impeded for membrane localization has just begun to unravel the physiological role of MISS in vivo and their contribution to ERα-mediated metabolic protection. Finally, we discuss novel perspectives for the design of tissue-selective ER modulators.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Acconcia, F., Ascenzi, P., Bocedi, A., Spisni, E., Tomasi, V., Trentalance, A., Visca, p., & Marino, M. (2005). Palmitoylation-dependent estrogen receptor alpha membrane localization: Regulation by 17beta-estradiol. Molecular Biology of the Cell, 16, 231–237.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Adlanmerini, M., Solinhac, R., Abot, A., Fabre, A., Raymond-Letron, I., Guihot, A. L., Boudou, F., Sautier, L., Vessieres, E., Kim, S. H., Liere, P., Fontaine, C., Krust, A., Chambon, P., Katzenellenbogen, J. A., Gourdy, P., Shaul, P. W., Henrion, D., Arnal, J. F., & Lenfant, F. (2014). Mutation of the palmitoylation site of estrogen receptor alpha in vivo reveals tissue-specific roles for membrane versus nuclear actions. Proceedings of the National Academy of Sciences of the United States of America, 111, E283–E290.

    Article  CAS  PubMed  Google Scholar 

  • Ahlbory-Dieker, D. L., Stride, B. D., Leder, G., Schkoldow, J., Trolenberg, S., Seidel, H., Otto, C., Sommer, A., Parker, M. G., Schutz, G., & Wintermantel, T. M. (2009). DNA binding by estrogen receptor-alpha is essential for the transcriptional response to estrogen in the liver and the uterus. Molecular Endocrinology, 23, 1544–1555.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ali, S., Metzger, D., Bornert, J. M., & Chambon, P. (1993). Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. The EMBO Journal, 12, 1153–1160.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Arao, Y., Hamilton, K. J., Ray, M. K., Scott, G., Mishina, Y., & Korach, K. S. (2011). Estrogen receptor alpha AF-2 mutation results in antagonist reversal and reveals tissue selective function of estrogen receptor modulators. Proceedings of the National Academy of Sciences of the United States of America, 108, 14986–14991.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Arnal, J. F., Fontaine, C., Billon-gales, A., Favre, J., Laurell, H., Lenfant, F., & Gourdy, P. (2010). Estrogen receptors and endothelium. Arteriosclerosis, Thrombosis, and Vascular Biology, 30, 1506–1512.

    Article  CAS  PubMed  Google Scholar 

  • Arnal, J. F., Lenfant, F., Metivier, R., Flouriot, G., Henrion, D., Adlanmerini, M., Fontaine, C., Gourdy, P., Chambon, P., Katzenellenbogen, B., & Katzenellenbogen, J. (2017). Membrane and nuclear estrogen receptor alpha actions: From tissue specificity to medical implications. Physiological Reviews, 97, 1045–1087.

    Article  PubMed  Google Scholar 

  • Ascenzi, P., Bocedi, A., & Marino, M. (2006). Structure-function relationship of estrogen receptor alpha and beta: Impact on human health. Molecular Aspects of Medicine, 27, 299–402.

    Article  CAS  PubMed  Google Scholar 

  • Billon-Gales, A., Fontaine, C., Douin-Echinard, V., Delpy, L., Berges, H., Calippe, B., Lenfant, F., Laurell, H., Guery, J. C., Gourdy, P., & Arnal, J. F. (2009a). Endothelial estrogen receptor-alpha plays a crucial role in the atheroprotective action of 17beta-estradiol in low-density lipoprotein receptor-deficient mice. Circulation, 120, 2567–2576.

    Article  CAS  PubMed  Google Scholar 

  • Billon-gales, A., Fontaine, C., Filipe, C., Douin-Echinard, V., Fouque, M. J., Flouriot, G., Gourdy, P., Lenfant, F., Laurell, H., Krust, A., Chambon, P., & Arnal, J. F. (2009b). The transactivating function 1 of estrogen receptor {alpha} is dispensable for the vasculoprotective actions of 17{beta}-estradiol. Proceedings of the National Academy of Sciences of the United States of America, 106, 2053–2058.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Billon-Gales, A., Krust, A., Fontaine, C., Abot, A., Flouriot, G., Toutain, C., Berges, H., Gadeau, A. P., Lenfant, F., Gourdy, P., Chambon, P., & Arnal, J. F. (2011). Activation function 2 (AF2) of estrogen receptor-{alpha} is required for the atheroprotective action of estradiol but not to accelerate endothelial healing. Proceedings of the National Academy of Sciences of the United States of America, 108, 13311–13316.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Bolego, C., Cignarella, A., Sanvito, P., Pelosi, V., Pellegatta, F., Puglisi, L., & Pinna, C. (2005). The acute estrogenic dilation of rat aorta is mediated solely by selective estrogen receptor-alpha agonists and is abolished by estrogen deprivation. The Journal of Pharmacology and Experimental Therapeutics, 313, 1203–1208.

    Article  CAS  PubMed  Google Scholar 

  • Bonds, D. E., Lasser, N., Qi, L., Brzyski, R., Caan, B., Heiss, G., Limacher, M. C., Liu, J. H., Mason, E., Oberman, A., O’sullivan, M. J., Phillips, L. S., Prineas, R. J., & Tinker, L. (2006). The effect of conjugated equine oestrogen on diabetes incidence: The women’s health initiative randomised trial. Diabetologia, 49, 459–468.

    Article  CAS  PubMed  Google Scholar 

  • Borjesson, A. E., Windahl, S. H., Lagerquist, M. K., Engdahl, C., Frenkel, B., Moverare-Skrtic, S., Sjogren, K., Kindblom, J. M., Stubelius, A., Islander, U., Antal, M. C., Krust, A., Chambon, P., & Ohlsson, C. (2011). Roles of transactivating functions 1 and 2 of estrogen receptor-{alpha} in bone. Proceedings of the National Academy of Sciences of the United States of America, 108, 6288–6293.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Brouchet, L., Krust, A., Dupont, S., Chambon, P., Bayard, F., & Arnal, J. F. (2001). Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta. Circulation, 103, 423–428.

    Article  CAS  PubMed  Google Scholar 

  • Brzozowski, A. M., Pike, A. C., Dauter, Z., Hubbard, R. E., Bonn, T., Engstrom, O., Ohman, L., Greene, G. L., Gustafsson, J. A., & Carlquist, M. (1997). Molecular basis of agonism and antagonism in the oestrogen receptor. Nature, 389, 753–758.

    Article  CAS  PubMed  Google Scholar 

  • Bunone, G., Briand, P. A., Miksicek, R. J., & Picard, D. (1996). Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. The EMBO Journal, 15, 2174–2183.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Carson-Jurica, M. A., Schrader, W. T., & O’malley, B. W. (1990). Steroid receptor family: Structure and functions. Endocrine Reviews, 11, 201–220.

    Article  CAS  PubMed  Google Scholar 

  • Caulin-Glaser, T., Garcia-Cardena, G., Sarrel, P., Sessa, W. C., & Bender, J. R. (1997). 17 beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization. Circulation Research, 81, 885–892.

    Article  CAS  PubMed  Google Scholar 

  • Chambliss, K. L., Yuhanna, I. S., Anderson, R. G., Mendelsohn, M. E., & Shaul, P. W. (2002). ERbeta has nongenomic action in caveolae. Molecular Endocrinology, 16, 938–946.

    CAS  PubMed  Google Scholar 

  • Chambliss, K. L., Wu, Q., Oltmann, S., Konaniah, E. S., Umetani, M., Korach, K. S., Thomas, G. D., Mineo, C., Yuhanna, I. S., Kim, S. H., Madak-Erdogan, Z., Maggi, A., Dineen, S. P., Roland, C. L., Hui, D. Y., Brekken, R. A., Katzenellenbogen, J. A., Katzenellenbogen, B. S., & Shaul, P. W. (2010). Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. The Journal of Clinical Investigation, 120, 2319–2330.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Chambliss, K. L., Barrera, J., Umetani, M., Umetani, J., Kim, S. H., Madak-Erdogan, Z., Huang, L., Katzenellenbogen, B. S., Katzenellenbogen, J. A., Mineo, C., & Shaul, P. W. (2016). Nonnuclear estrogen receptor activation improves hepatic steatosis in female mice. Endocrinology, 157, 3731–3741.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Chantalat, E., Boudou, F., Laurell, H., Palierne, G., Houtman, R., Melchers, D., Rochaix, P., Filleron, T., Stella, A., Burlet-Schiltz, O., Brouchet, A., Flouriot, G., Metivier, R., Arnal, J. F., Fontaine, C., & Lenfant, F. (2016). The AF-1-deficient estrogen receptor ERalpha46 isoform is frequently expressed in human breast tumors. Breast Cancer Research, 18, 123.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Chen, Z., Yuhanna, I. S., Galcheva-Gargova, Z., Karas, R. H., Mendelsohn, M. E., & Shaul, P. W. (1999). Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. The Journal of Clinical Investigation, 103, 401–406.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Chen, D. B., Bird, I. M., Zheng, J., & Magness, R. R. (2004). Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells. Endocrinology, 145, 113–125.

    Article  CAS  PubMed  Google Scholar 

  • Cooke, P. S., Heine, P. A., Taylor, J. A., & Lubahn, D. B. (2001). The role of estrogen and estrogen receptor-alpha in male adipose tissue. Molecular and Cellular Endocrinology, 178, 147–154.

    Article  CAS  PubMed  Google Scholar 

  • Dan, P., Cheung, J. C., Scriven, D. R., & Moore, E. D. (2003). Epitope-dependent localization of estrogen receptor-alpha, but not -beta, in en face arterial endothelium. American Journal of Physiology. Heart and Circulatory Physiology, 284, H1295–H1306.

    Article  CAS  PubMed  Google Scholar 

  • Danielian, P. S., White, R., Lees, J. A., & Parker, M. G. (1992). Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. The EMBO Journal, 11, 1025–1033.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Darblade, B., Pendaries, C., Krust, A., Dupont, S., Fouque, M. J., Rami, J., Chambon, P., Bayard, F., & Arnal, J. F. (2002). Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor. Circulation Research, 90, 413–419.

    Article  CAS  PubMed  Google Scholar 

  • Davis, K. E., Carstens, E. J., Irani, B. G., Gent, L. M., Hahner, L. M., & Clegg, D. J. (2014). Sexually dimorphic role of G protein-coupled estrogen receptor (GPER) in modulating energy homeostasis. Hormones and Behavior, 66, 196–207.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Dupont, S., Krust, A., Gansmuller, A., Dierich, A., Chambon, P., & Mark, M. (2000). Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development, 127, 4277–4291.

    CAS  PubMed  Google Scholar 

  • Filardo, E. J., Quinn, J. A., Bland, K. I., & Frackelton, A. R., Jr. (2000). Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Molecular Endocrinology, 14, 1649–1660.

    Article  CAS  PubMed  Google Scholar 

  • Foulds, C. E., Feng, Q., Ding, C., Bailey, S., Hunsaker, T. L., Malovannaya, A., Hamilton, R. A., Gates, L. A., Zhang, Z., Li, C., Chan, D., Bajaj, A., Callaway, C. G., Edwards, D. P., Lonard, D. M., Tsai, S. Y., Tsai, M. J., Qin, J., & O’Malley, B. W. (2013). Proteomic analysis of coregulators bound to ERalpha on DNA and nucleosomes reveals coregulator dynamics. Molecular Cell, 51, 185–199.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Garcia-Cardena, G., Oh, P., Liu, J., Schnitzer, J. E., & Sessa, W. C. (1996). Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: Implications for nitric oxide signaling. Proceedings of the National Academy of Sciences of the United States of America, 93, 6448–6453.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Green, S., & Chambon, P. (1987). Oestradiol induction of a glucocorticoid-responsive gene by a chimaeric receptor. Nature, 325, 75–78.

    Article  CAS  PubMed  Google Scholar 

  • Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J. M., Argos, P., & Chambon, P. (1986). Human oestrogen receptor cDNA: Sequence, expression and homology to v-erb-A. Nature, 320, 134–139.

    Article  CAS  PubMed  Google Scholar 

  • Grumbach, M. M., & Auchus, R. J. (1999). Estrogen: Consequences and implications of human mutations in synthesis and action. The Journal of Clinical Endocrinology and Metabolism, 84, 4677–4694.

    CAS  PubMed  Google Scholar 

  • Guillaume, M., Handgraaf, S., Fabre, A., Raymond-Letron, I., Riant, E., Montagner, A., Vinel, A., Buscato, M., Smirnova, N., Fontaine, C., Guillou, H., Arnal, J. F., & Gourdy, P. (2017). Selective activation of estrogen receptor alpha activation function-1 is sufficient to prevent obesity, steatosis, and insulin resistance in mouse. The American Journal of Pathology, 187, 1273–1287.

    Article  CAS  PubMed  Google Scholar 

  • Hafezi-Moghadam, A., Simoncini, T., Yang, Z., Limbourg, F. P., Plumier, J. C., Rebsamen, M. C., Hsieh, C. M., Chui, D. S., Thomas, K. L., Prorock, A. J., Laubach, V. E., Moskowitz, M. A., French, B. A., Ley, K., & Liao, J. K. (2002). Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nature Medicine, 8, 473–479.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hammes, S. R., & Levin, E. R. (2007). Extranuclear steroid receptors: Nature and actions. Endocrine Reviews, 28, 726–741.

    Article  CAS  PubMed  Google Scholar 

  • Handgraaf, S., Riant, E., Fabre, A., Waget, A., Burcelin, R., Liere, P., Krust, A., Chambon, P., Arnal, J. F., & Gourdy, P. (2013). Prevention of obesity and insulin resistance by estrogens requires ERalpha activation function-2 (ERalphaAF-2), whereas ERalphaAF-1 is dispensable. Diabetes, 62, 4098–4108.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Harrington, W. R., Kim, S. H., Funk, C. C., Madak-Erdogan, Z., Schiff, R., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (2006). Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action. Molecular Endocrinology, 20, 491–502.

    Article  CAS  PubMed  Google Scholar 

  • Heine, P. A., Taylor, J. A., Iwamoto, G. A., Lubahn, D. B., & Cooke, P. S. (2000). Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proceedings of the National Academy of Sciences of the United States of America, 97, 12729–12734.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., Tujague, M., Strom, A., Treuter, E., Warner, M., & Gustafsson, J. A. (2007). Estrogen receptors: How do they signal and what are their targets. Physiological Reviews, 87, 905–931.

    Article  CAS  PubMed  Google Scholar 

  • Hewitt, S. C., Li, L., Grimm, S. A., Winuthayanon, W., Hamilton, K. J., Pockette, B., Rubel, C. A., Pedersen, L. C., Fargo, D., Lanz, R. B., Demayo, F. J., Schutz, G., & Korach, K. S. (2014). Novel DNA motif binding activity observed in vivo with an estrogen receptor alpha mutant mouse. Molecular Endocrinology, 28, 899–911.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Horwitz, K. B., Jackson, T. A., Bain, D. L., Richer, J. K., Takimoto, G. S., & Tung, L. (1996). Nuclear receptor coactivators and corepressors. Molecular Endocrinology, 10, 1167–1177.

    CAS  PubMed  Google Scholar 

  • Iafrati, M. D., Karas, R. H., Ronovitz, M., Kim, S., Sullivan, T. R., Jr., Lubahn, D. B., O’donnell, T. F., Jr., Korach, K. S., & Mendelsohn, M. E. (1997). Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nature Medicine, 3, 545–548.

    Article  CAS  PubMed  Google Scholar 

  • Jakacka, M., Ito, M., Martinson, F., Ishikawa, T., Lee, E. J., & Jameson, J. L. (2002). An estrogen receptor (ER)alpha deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo. Molecular Endocrinology, 16, 2188–2201.

    Article  CAS  PubMed  Google Scholar 

  • Jensen, E. V., & Desombre, E. R. (1973). Estrogen-receptor interaction. Science, 182, 126–134.

    Article  CAS  PubMed  Google Scholar 

  • Jones, M. E., Thorburn, A. W., Britt, K. L., Hewitt, K. N., Wreford, N. G., PROIETTO, J., Oz, O. K., Leury, B. J., Robertson, K. M., Yao, S., & Simpson, E. R. (2000). Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proceedings of the National Academy of Sciences of the United States of America, 97, 12735–12740.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kanaya, A. M., Herrington, D., Vittinghoff, E., Lin, F., Grady, D., Bittner, V., Cauley, J. A., & Barrett-Connor, E. (2003). Glycemic effects of postmenopausal hormone therapy: The heart and estrogen/progestin replacement study. A randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine, 138, 1–9.

    Article  CAS  PubMed  Google Scholar 

  • Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., Metzger, D., & Chambon, P. (1995). Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science, 270, 1491–1494.

    Article  CAS  PubMed  Google Scholar 

  • Krust, A., Green, S., Argos, P., Kumar, V., Walter, P., Bornert, J. M., & Chambon, P. (1986). The chicken oestrogen receptor sequence: Homology with v-erbA and the human oestrogen and glucocorticoid receptors. The EMBO Journal, 5, 891–897.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Kukowska-Latallo, J. F., Candido, K. A., Cao, Z., Nigavekar, S. S., Majoros, I. J., Thomas, T. P., Balogh, L. P., Khan, M. K., & Baker, J. R., Jr. (2005). Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Research, 65, 5317–5324.

    Article  CAS  PubMed  Google Scholar 

  • Kumar, R., & Thompson, E. B. (1999). The structure of the nuclear hormone receptors. Steroids, 64, 310–319.

    Article  CAS  PubMed  Google Scholar 

  • Kumar, P., Wu, Q., Chambliss, K. L., Yuhanna, I. S., Mumby, S. M., Mineo, C., Tall, G. G., & Shaul, P. W. (2007). Direct interactions with G alpha i and G betagamma mediate nongenomic signaling by estrogen receptor alpha. Molecular Endocrinology, 21, 1370–1380.

    Article  CAS  PubMed  Google Scholar 

  • Lange, C. A., Gioeli, D., Hammes, S. R., & Marker, P. C. (2007). Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer. Annual Review of Physiology, 69, 171–199.

    Article  CAS  PubMed  Google Scholar 

  • Langer, G., Bader, B., Meoli, L., Isensee, J., Delbeck, M., Noppinger, P. R., & Otto, C. (2010). A critical review of fundamental controversies in the field of GPR30 research. Steroids, 75, 603–610.

    Article  CAS  PubMed  Google Scholar 

  • Lantin-Hermoso, R. L., Rosenfeld, C. R., Yuhanna, I. S., German, Z., Chen, Z., & Shaul, P. W. (1997). Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. The American Journal of Physiology, 273, L119–L126.

    CAS  PubMed  Google Scholar 

  • Lavinsky, R. M., Jepsen, K., Heinzel, T., Torchia, J., Mullen, T. M., Schiff, R., Del-Rio, A. L., Ricote, M., Ngo, S., Gemsch, J., Hilsenbeck, S. G., Osborne, C. K., Glass, C. K., Rosenfeld, M. G., & Rose, D. W. (1998). Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proceedings of the National Academy of Sciences of the United States of America, 95, 2920–2925.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Le May, C., Chu, K., Hu, M., Ortega, C. S., Simpson, E. R., Korach, K. S., Tsai, M. J., & Mauvais-Jarvis, F. (2006). Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proceedings of the National Academy of Sciences of the United States of America, 103, 9232–9237.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Le Romancer, M., Treilleux, I., Leconte, N., Robin-Lespinasse, Y., Sentis, S., Bouchekioua-Bouzaghou, K., Goddard, S., Gobert-Gosse, S., & Corbo, L. (2008). Regulation of estrogen rapid signaling through arginine methylation by PRMT1. Molecular Cell, 31, 212–221.

    Article  CAS  PubMed  Google Scholar 

  • Le Romancer, M., Poulard, C., Cohen, P., Sentis, S., Renoir, J. M., & Corbo, L. (2011). Cracking the estrogen receptor’s posttranslational code in breast tumors. Endocrine Reviews, 32, 597–622.

    Article  CAS  PubMed  Google Scholar 

  • Lees, J. A., Fawell, S. E., & Parker, M. G. (1989). Identification of constitutive and steroid-dependent transactivation domains in the mouse oestrogen receptor. Journal of Steroid Biochemistry, 34, 33–39.

    Article  CAS  PubMed  Google Scholar 

  • Leong, H., Sloan, J. R., Nash, P. D., & Greene, G. L. (2005). Recruitment of histone deacetylase 4 to the N-terminal region of estrogen receptor alpha. Molecular Endocrinology, 19, 2930–2942.

    Article  CAS  PubMed  Google Scholar 

  • Levin, E. R. (2009). G protein-coupled receptor 30: Estrogen receptor or collaborator? Endocrinology, 150, 1563–1565.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Levin, E. R., & Hammes, S. R. (2016). Nuclear receptors outside the nucleus: Extranuclear signalling by steroid receptors. Nature Reviews. Molecular Cell Biology, 17, 783–797.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Levin, E. R., & Pietras, R. J. (2008). Estrogen receptors outside the nucleus in breast cancer. Breast Cancer Research and Treatment, 108, 351–361.

    Article  CAS  PubMed  Google Scholar 

  • Li, L., Haynes, M. P., & Bender, J. R. (2003). Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells. Proceedings of the National Academy of Sciences of the United States of America, 100, 4807–4812.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Liu, S., & Mauvais-Jarvis, F. (2010). Minireview: Estrogenic protection of beta-cell failure in metabolic diseases. Endocrinology, 151, 859–864.

    Article  CAS  PubMed  Google Scholar 

  • Liu, Z., Merkurjev, D., Yang, F., Li, W., Oh, S., Friedman, M. J., Song, X., Zhang, F., Ma, Q., Ohgi, K. A., Krones, A., & Rosenfeld, M. G. (2014). Enhancer activation requires trans-recruitment of a mega transcription factor complex. Cell, 159, 358–373.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Lonard, D. M., & O’malley, B. W. (2007). Nuclear receptor coregulators: Judges, juries, and executioners of cellular regulation. Molecular Cell, 27, 691–700.

    Article  CAS  PubMed  Google Scholar 

  • Louet, J. F., Lemay, C., & Mauvais-Jarvis, F. (2004). Antidiabetic actions of estrogen: Insight from human and genetic mouse models. Current Atherosclerosis Reports, 6, 180–185.

    Article  PubMed  Google Scholar 

  • Lubahn, D. B., Moyer, J. S., Golding, T. S., Couse, J. F., Korach, K. S., & Smithies, O. (1993). Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proceedings of the National Academy of Sciences of the United States of America, 90, 11162–11166.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Madak-Erdogan, Z., Kim, S. H., Gong, P., Zhao, Y. C., Zhang, H., Chambliss, K. L., Carlson, K. E., Mayne, C. G., Shaul, P. W., Korach, K. S., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (2016). Design of pathway preferential estrogens that provide beneficial metabolic and vascular effects without stimulating reproductive tissues. Science Signaling, 9, ra53.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Mader, S., Kumar, V., De Verneuil, H., & Chambon, P. (1989). Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element. Nature, 338, 271–274.

    Article  CAS  PubMed  Google Scholar 

  • Mangelsdorf, D. J., & Evans, R. M. (1995). The RXR heterodimers and orphan receptors. Cell, 83, 841–850.

    Article  CAS  PubMed  Google Scholar 

  • Margolis, K. L., Bonds, D. E., Rodabough, R. J., Tinker, L., Phillips, L. S., Allen, C., Bassford, T., Burke, G., Torrens, J., & Howard, B. V. (2004). Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: Results from the Women's Health Initiative Hormone Trial. Diabetologia, 47, 1175–1187.

    Article  CAS  PubMed  Google Scholar 

  • Marino, M., & Ascenzi, P. (2008). Membrane association of estrogen receptor alpha and beta influences 17beta-estradiol-mediated cancer cell proliferation. Steroids, 73, 853–858.

    Article  CAS  PubMed  Google Scholar 

  • Mauvais-Jarvis, F. (2016). Role of sex steroids in beta cell function, growth, and survival. Trends in Endocrinology and Metabolism, 27, 844–855.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Mauvais-Jarvis, F., Manson, J. E., Stevenson, J. C., & Fonseca, V. A. (2017). Menopausal hormone therapy and type 2 diabetes prevention: Evidence, mechanisms, and clinical implications. Endocrine Reviews, 38, 173–188.

    Article  PubMed  Google Scholar 

  • Mcdevitt, M. A., Glidewell-Kenney, C., Jimenez, M. A., Ahearn, P. C., Weiss, J., Jameson, J. L., & Levine, J. E. (2008). New insights into the classical and non-classical actions of estrogen: Evidence from estrogen receptor knock-out and knock-in mice. Molecular and Cellular Endocrinology, 290, 24–30.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Mckenna, N. J., & O’malley, B. W. (2002). Combinatorial control of gene expression by nuclear receptors and coregulators. Cell, 108, 465–474.

    Article  CAS  PubMed  Google Scholar 

  • Mendelsohn, M. E., & Karas, R. H. (2010). Rapid progress for non-nuclear estrogen receptor signaling. The Journal of Clinical Investigation, 120, 2277–2279.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Metivier, R., Stark, A., Flouriot, G., Hubner, M. R., Brand, H., Penot, G., Manu, D., Denger, S., Reid, G., Kos, M., Russell, R. B., Kah, O., Pakdel, F., & Gannon, F. (2002). A dynamic structural model for estrogen receptor-alpha activation by ligands, emphasizing the role of interactions between distant A and E domains. Molecular Cell, 10, 1019–1032.

    Article  CAS  PubMed  Google Scholar 

  • Metivier, R., Penot, G., Carmouche, R. P., Hubner, M. R., Reid, G., Denger, S., Manu, D., Brand, H., Kos, M., Benes, V., & Gannon, F. (2004). Transcriptional complexes engaged by apo-estrogen receptor-alpha isoforms have divergent outcomes. The EMBO Journal, 23, 3653–3666.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Metzger, D., Ali, S., Bornert, J. M., & Chambon, P. (1995). Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells. The Journal of Biological Chemistry, 270, 9535–9542.

    Article  CAS  PubMed  Google Scholar 

  • Meyer, M. R., Prossnitz, E. R., & Barton, M. (2011). The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function. Vascular Pharmacology, 55, 17–25.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Moras, D., & Gronemeyer, H. (1998). The nuclear receptor ligand-binding domain: Structure and function. Current Opinion in Cell Biology, 10, 384–391.

    Article  CAS  PubMed  Google Scholar 

  • Morishima, A., Grumbach, M. M., Simpson, E. R., Fisher, C., & Qin, K. (1995). Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. The Journal of Clinical Endocrinology and Metabolism, 80, 3689–3698.

    CAS  PubMed  Google Scholar 

  • Mosselman, S., Polman, J., & Dijkema, R. (1996). ER beta: Identification and characterization of a novel human estrogen receptor. FEBS Letters, 392, 49–53.

    Article  CAS  PubMed  Google Scholar 

  • Nadal, A., Alonso-Magdalena, P., Soriano, S., Quesada, I., & Ropero, A. B. (2009). The pancreatic beta-cell as a target of estrogens and xenoestrogens: Implications for blood glucose homeostasis and diabetes. Molecular and Cellular Endocrinology, 304, 63–68.

    Article  CAS  PubMed  Google Scholar 

  • O’brien, J. E., Peterson, T. J., Tong, M. H., Lee, E. J., Pfaff, L. E., Hewitt, S. C., Korach, K. S., Weiss, J., & Jameson, J. L. (2006). Estrogen-induced proliferation of uterine epithelial cells is independent of estrogen receptor alpha binding to classical estrogen response elements. The Journal of Biological Chemistry, 281, 26683–26692.

    Article  CAS  PubMed  Google Scholar 

  • Palierne, G., Fabre, A., Solinhac, R., Le Peron, C., Avner, S., Lenfant, F., Fontaine, C., Salbert, G., Flouriot, G., Arnal, J. F., & Metivier, R. (2016). Changes in gene expression and estrogen receptor cistrome in mouse liver upon acute E2 treatment. Molecular Endocrinology, 30, 709–732.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Pare, G., Krust, A., Karas, R. H., Dupont, S., Aronovitz, M., Chambon, P., & Mendelsohn, M. E. (2002). Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circulation Research, 90, 1087–1092.

    Article  CAS  PubMed  Google Scholar 

  • Park, C. J., Zhao, Z., Glidewell-Kenney, C., Lazic, M., Chambon, P., Krust, A., Weiss, J., Clegg, D. J., Dunaif, A., Jameson, J. L., & Levine, J. E. (2011). Genetic rescue of nonclassical ERalpha signaling normalizes energy balance in obese Eralpha-null mutant mice. The Journal of Clinical Investigation, 121, 604–612.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Pedram, A., Razandi, M., Sainson, R. C., Kim, J. K., Hughes, C. C., & Levin, E. R. (2007). A conserved mechanism for steroid receptor translocation to the plasma membrane. The Journal of Biological Chemistry, 282, 22278–22288.

    Article  CAS  PubMed  Google Scholar 

  • Pedram, A., Razandi, M., Kim, J. K., O’mahony, F., Lee, E. Y., Luderer, U., & Levin, E. R. (2009). Developmental phenotype of a membrane only estrogen receptor alpha (MOER) mouse. The Journal of Biological Chemistry, 284, 3488–3495.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Pedram, A., Razandi, M., O’mahony, F., Harvey, H., Harvey, B. J., & Levin, E. R. (2013). Estrogen reduces lipid content in the liver exclusively from membrane receptor signaling. Science Signaling, 6, ra36.

    Article  CAS  PubMed  Google Scholar 

  • Pedram, A., Razandi, M., Lewis, M., Hammes, S., & Levin, E. R. (2014). Membrane-localized estrogen receptor alpha is required for normal organ development and function. Developmental Cell, 29, 482–490.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Pedram, A., Razandi, M., Blumberg, B., & Levin, E. R. (2016). Membrane and nuclear estrogen receptor alpha collaborate to suppress adipogenesis but not triglyceride content. The FASEB Journal, 30, 230–240.

    Article  CAS  PubMed  Google Scholar 

  • Pendaries, C., Darblade, B., Rochaix, P., Krust, A., Chambon, P., Korach, K. S., Bayard, F., & Arnal, J. F. (2002). The AF-1 activation-function of ERalpha may be dispensable to mediate the effect of estradiol on endothelial NO production in mice. Proceedings of the National Academy of Sciences of the United States of America, 99, 2205–2210.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Razandi, M., Pedram, A., Greene, G. L., & Levin, E. R. (1999). Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: Studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells. Molecular Endocrinology, 13, 307–319.

    CAS  PubMed  Google Scholar 

  • Reis, S. E., Gloth, S. T., Blumenthal, R. S., Resar, J. R., Zacur, H. A., Gerstenblith, G., & Brinker, J. A. (1994). Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation, 89, 52–60.

    Article  CAS  PubMed  Google Scholar 

  • Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., & Prossnitz, E. R. (2005). A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science, 307, 1625–1630.

    Article  CAS  PubMed  Google Scholar 

  • Riant, E., Waget, A., Cogo, H., Arnal, J. F., Burcelin, R., & Gourdy, P. (2009). Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology, 150, 2109–2117.

    Article  CAS  PubMed  Google Scholar 

  • Russell, K. S., Haynes, M. P., Sinha, D., Clerisme, E., & Bender, J. R. (2000). Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proceedings of the National Academy of Sciences of the United States of America, 97, 5930–5935.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Schwabe, J. W., Neuhaus, D., & Rhodes, D. (1990). Solution structure of the DNA-binding domain of the oestrogen receptor. Nature, 348, 458–461.

    Article  CAS  PubMed  Google Scholar 

  • Simoncini, T., Hafezi-Moghadam, A., Brazil, D. P., Ley, K., Chin, W. W., & Liao, J. K. (2000). Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature, 407, 538–541.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., & Korach, K. S. (1994). Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. The New England Journal of Medicine, 331, 1056–1061.

    Article  CAS  PubMed  Google Scholar 

  • Stefano, G. B., Prevot, V., Beauvillain, J. C., Cadet, P., Fimiani, C., Welters, I., Fricchione, G. L., Breton, C., Lassalle, P., Salzet, M., & Bilfinger, T. V. (2000). Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia. Circulation, 101, 1594–1597.

    Article  CAS  PubMed  Google Scholar 

  • Thomas, C., & Gustafsson, J. A. (2011). The different roles of ER subtypes in cancer biology and therapy. Nature Reviews Cancer, 11, 597–608.

    Article  CAS  PubMed  Google Scholar 

  • Tiano, J. P., & Mauvais-Jarvis, F. (2012a). Importance of oestrogen receptors to preserve functional beta-cell mass in diabetes. Nature Reviews. Endocrinology, 8, 342–351.

    Article  CAS  PubMed  Google Scholar 

  • Tiano, J. P., & Mauvais-Jarvis, F. (2012b). Molecular mechanisms of estrogen receptors’ suppression of lipogenesis in pancreatic beta-cells. Endocrinology, 153, 2997–3005.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Tiano, J. P., Delghingaro-Augusto, V., Le May, C., Liu, S., Kaw, M. K., Khuder, S. S., Latour, M. G., Bhatt, S. A., Korach, K. S., Najjar, S. M., Prentki, M., & Mauvais-Jarvis, F. (2011). Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents beta cell failure in rodent models of type 2 diabetes. The Journal of Clinical Investigation, 121, 3331–3342.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Vinel, A., Hay, E., Valera, M. C., Buscato, M., Adlanmerini, M., Guillaume, M., Cohen-Solal, M., Ohlsson, C., Lenfant, F., Arnal, J. F., & Fontaine, C. (2016). Role of ERalpha in the effect of estradiol on cancellous and cortical femoral bone in growing female mice. Endocrinology, 157, 2533–2544.

    Article  CAS  PubMed  Google Scholar 

  • Wedisinghe, L., & Perera, M. (2009). Diabetes and the menopause. Maturitas, 63, 200–203.

    Article  CAS  PubMed  Google Scholar 

  • Wu, Q., Chambliss, K., Umetani, M., Mineo, C., & Shaul, P. W. (2011). Non-nuclear estrogen receptor signaling in the endothelium. The Journal of Biological Chemistry, 286, 14737–14743.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ylikomi, T., Bocquel, M. T., Berry, M., Gronemeyer, H., & Chambon, P. (1992). Cooperation of proto-signals for nuclear accumulation of estrogen and progesterone receptors. The EMBO Journal, 11, 3681–3694.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Zhou, J., Li, Y. S., & Chien, S. (2014). Shear stress-initiated signaling and its regulation of endothelial function. Arteriosclerosis, Thrombosis, and Vascular Biology, 34, 2191–2198.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Raphael Metivier and Gilles Flouriot (Rennes, France), Pierre Chambon (Strasbourg, France), and John and Benita Katzenellenbogen (Urbana, USA) for long-term collaboration and fruitful discussions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maeva Guillaume .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Guillaume, M., Montagner, A., Fontaine, C., Lenfant, F., Arnal, JF., Gourdy, P. (2017). Nuclear and Membrane Actions of Estrogen Receptor Alpha: Contribution to the Regulation of Energy and Glucose Homeostasis. In: Mauvais-Jarvis, F. (eds) Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity. Advances in Experimental Medicine and Biology, vol 1043. Springer, Cham. https://doi.org/10.1007/978-3-319-70178-3_19

Download citation

Publish with us

Policies and ethics